Telomerase RNA component

TERC is a Long non-coding RNA (lncRNA) ranging in length from ~150nt in ciliates to 400-600nt in vertebrates, and 1,300nt in yeast (Alnafakh). Mature human TERC (hTR) is 451nt in length.{{cite journal | vauthors = Roake CM, Chen L, Chakravarthy AL, Ferrell JE, Raffa GD, Artandi SE | title = Disruption of Telomerase RNA Maturation Kinetics Precipitates Disease | journal = Molecular Cell | volume = 74 | issue = 4 | pages = 688–700.e3 | date = May 2019 | pmid = 30930056 | pmc = 6525023 | doi = 10.1016/j.molcel.2019.02.033 }} TERC has extensive secondary structural features over 4 principal conserved domains.{{cite journal | vauthors = Alnafakh RA, Adishesh M, Button L, Saretzki G, Hapangama DK | title = Telomerase and Telomeres in Endometrial Cancer | journal = Frontiers in Oncology | volume = 9 | pages = 344 | date = 2019 | pmid = 31157162 | pmc = 6533802 | doi = 10.3389/fonc.2019.00344 | language = en | doi-access = free }} The core domain, the largest domain at the 5’ end of TERC, contains the CUAAC Telomere template sequence. Its secondary structure consists of a large loop containing the template sequence, a P1 loop-closing helix, and a P2/P3 pseudoknot.{{cite journal | vauthors = Zhang Q, Kim NK, Feigon J | title = Architecture of human telomerase RNA | journal = Proceedings of the National Academy of Sciences of the United States of America | volume = 108 | issue = 51 | pages = 20325–20332 | date = December 2011 | pmid = 21844345 | pmc = 3251123 | doi = 10.1073/pnas.1100279108 | bibcode = 2011PNAS..10820325Z | doi-access = free }} The core domain and CR4/CR5 conserved domain associate with TERT, and are the only domains of TERC necessary for in vitro catalytic activity of telomerase.{{cite journal | vauthors = Webb CJ, Zakian VA | title = Telomerase RNA is more than a DNA template | journal = RNA Biology | volume = 13 | issue = 8 | pages = 683–689 | date = August 2016 | pmid = 27245259 | pmc = 4993324 | doi = 10.1080/15476286.2016.1191725 }} The 3’ end of TERC consists of a conserved H/ACA domain, a 2 hairpin structure connected by a single-stranded hinge and bordered on the 3’ end by a single-stranded ACA sequence. The H/ACA domain binds Dyskerin, GAR1, NOP10, NHP2, to form an H/ACA RNP complex. The conserved CR7 domain is also localized at the 3’ end of TERC, and contains a 3nt CAB (Cajal body Localisation) box which binds TCAB1.

File:Illustration_-_hTR_and_associated_proteins_of_telomerase_complex.png

Telomerase is a ribonucleoprotein polymerase that maintains telomere ends by addition of the telomere repeat TTAGGG. This repeat does vary across eukaryotes (see the table on the telomere article for a complete list). The enzyme consists of a protein component (TERT) with reverse transcriptase activity, and an RNA component, encoded by this gene, that serves as a template for the telomere repeat. CCCUAA found near position 50 of the vertebrate TERC sequence acts as the template. Telomerase expression plays a role in cellular senescence, as it is normally repressed in postnatal somatic cells resulting in progressive shortening of telomeres. Deregulation of telomerase expression in somatic cells may be involved in oncogenesis. Studies in mice suggest that telomerase also participates in chromosomal repair, since de novo synthesis of telomere repeats may occur at double-stranded breaks.{{cite web | title = Entrez Gene: TERC telomerase RNA component | url = https://www.ncbi.nlm.nih.gov/sites/entrez?Db=gene&Cmd=ShowDetailView&TermToSearch=7012 }} Homologs of TERC can also be found in the Gallid herpes viruses.{{cite journal | vauthors = Fragnet L, Kut E, Rasschaert D | title = Comparative functional study of the viral telomerase RNA based on natural mutations | journal = The Journal of Biological Chemistry | volume = 280 | issue = 25 | pages = 23502–23515 | date = June 2005 | pmid = 15811851 | doi = 10.1074/jbc.M501163200 | s2cid = 24301693 | doi-access = free }}

The core domain of TERC contains the RNA template from which TERT synthesizes TTAGGG telomeric repeats. Unlike in other RNPs, in telomerase, the protein TERT is catalytic while the lncRNA TERC is structural, rather than acting as a ribozyme.{{cite journal | vauthors = Wang Y, Sušac L, Feigon J | title = Structural Biology of Telomerase | journal = Cold Spring Harbor Perspectives in Biology | volume = 11 | issue = 12 | pages = a032383 | date = December 2019 | pmid = 31451513 | pmc = 6886448 | doi = 10.1101/cshperspect.a032383 }} The core region of TERC and TERT are sufficient to reconstitute catalytic telomerase activity in vitro. The H/ACA domain of TERC recruits the Dyskerin complex (DKC1, GAR1, NOP10, NHP2), which stabilises TERC, increasing telomerase complex formation and overall catalytic activity. The CR7 domain binds TCAB1, which localizes telomerase to cajal bodies, further increasing telomerase catalytic activity. TERC is ubiquitously expressed, even in cells lacking telomerase activity and TERT expression.{{cite journal | vauthors = Shay JW, Wright WE | title = Telomeres and telomerase: three decades of progress | journal = Nature Reviews. Genetics | volume = 20 | issue = 5 | pages = 299–309 | date = May 2019 | pmid = 30760854 | doi = 10.1038/s41576-019-0099-1 | s2cid = 61156603 }} As a result, various TERT-independent functional roles of TERC have been proposed. 14 genes containing a TERC binding motif are directly transcriptionally regulated by TERC through RNA-DNA triplex formation-mediated increase of expression. TERC-mediated upregulation of Lin37, Trpg1l, tyrobp, Usp16 stimulates the NF-κB pathway, resulting in increased expression and secretion of inflammatory cytokines.{{cite journal | vauthors = Liu H, Yang Y, Ge Y, Liu J, Zhao Y | title = TERC promotes cellular inflammatory response independent of telomerase | journal = Nucleic Acids Research | volume = 47 | issue = 15 | pages = 8084–8095 | date = September 2019 | pmid = 31294790 | pmc = 6735767 | doi = 10.1093/nar/gkz584 }}

Unlike most lncRNAs which are assembled from introns by the spliceosome, hTR is directly transcribed from a dedicated promoter site located at genomic locus 3q26.2{{Cite web | title = OMIM Entry - * 602322 - TELOMERASE RNA COMPONENT; TERC | url = https://www.omim.org/entry/602322 | website = www.omim.org | access-date = 2020-03-02 }} by RNA polymerase II. Mature hTR is 451nt in length, but approximately 1/3 of cellular hTR transcripts at steady state have ~10nt genomically encoded 3’ tails. The majority of those extended hTR species have additional oligo-A 3’ extension. Processing of immature 3’-tailed hTR to mature 451nt hTR can be accomplished by direct 3’-5’ exoribonucleolytic degradation or by an indirect pathway of oligoadenylation by PAPD5, removal of 3’ oligo-A tail by the 3’-5’ RNA exonuclease PARN, and subsequent 3’-5’ exoribonucleolytic degradation. Extended hTR transcripts are also degraded by the RNA exosome.

The 5’ ends of hTR transcripts are also additionally processed. TGS-1 hypermethylation the 5'-methylguanosine cap to an N2,2,7 trimethylguanosine (TMG) cap, which inhibits hTR maturation.{{cite journal | vauthors = Chen L, Roake CM, Galati A, Bavasso F, Micheli E, Saggio I, Schoeftner S, Cacchione S, Gatti M, Artandi SE, Raffa GD | title = Loss of Human TGS1 Hypermethylase Promotes Increased Telomerase RNA and Telomere Elongation | journal = Cell Reports | volume = 30 | issue = 5 | pages = 1358–1372.e5 | date = February 2020 | pmid = 32023455 | pmc = 7156301 | doi = 10.1016/j.celrep.2020.01.004 }} Binding of the Dyskerin complex to transcribed H/ACA domains of hTR during transcription promotes termination of transcription. Control of the relative rates of these various competing pathways that activate or inhibit hTR maturation is a crucial element of regulation of overall telomerase activity.

Loss of function mutations in the TERC genomic locus have been associated with a variety of degenerative diseases. Mutations in TERC have been associated with dyskeratosis congenita,{{Cite book | vauthors = Rich RR | title = Clinical immunology : principles and practice | publisher = Elsevier Health Sciences | location = St. Louis, Mo. | date = 2018-01-13 | isbn = 978-0-7020-7039-6 | edition = Fifth | oclc = 1023865227 }} idiopathic pulmonary fibrosis,{{Cite book | vauthors = Swigris JJ, Brown KK | title = Idiopathic pulmonary fibrosis | publisher = Elsevier | location = St. Louis | date = 2018-07-25 | isbn = 978-0-323-54432-0 | oclc = 1053744041 }} aplastic anemia, and myelodysplasia. Overexpression and improper regulation of TERC have been associated with a variety of cancers. Upregulation of hTR is widely observed in patients with precancerous cervical phenotype as a result of HPV infection.{{cite journal | vauthors = Liu Y, Fan P, Yang Y, Xu C, Huang Y, Li D, Qing Q, Sun C, Zhou H | title = Human papillomavirus and human telomerase RNA component gene in cervical cancer progression | journal = Scientific Reports | volume = 9 | issue = 1 | pages = 15926 | date = November 2019 | pmid = 31685833 | pmc = 6828729 | doi = 10.1038/s41598-019-52195-5 | bibcode = 2019NatSR...915926L }} Overexpression of TERC enhances MDV-mediated oncogenesis,{{cite journal | vauthors = Kheimar A, Trimpert J, Groenke N, Kaufer BB | title = Overexpression of cellular telomerase RNA enhances virus-induced cancer formation | journal = Oncogene | volume = 38 | issue = 10 | pages = 1778–1786 | date = March 2019 | pmid = 30846849 | doi = 10.1038/s41388-018-0544-1 | s2cid = 53085869 }} and is observed in gastric carcinoma.{{cite journal | vauthors = Heine B, Hummel M, Demel G, Stein H | title = Demonstration of constant upregulation of the telomerase RNA component in human gastric carcinomas using in situ hybridization | journal = The Journal of Pathology | volume = 185 | issue = 2 | pages = 139–144 | date = June 1998 | pmid = 9713339 | doi = 10.1002/(SICI)1096-9896(199806)185:2<139::AID-PATH79>3.0.CO;2-L | s2cid = 21966828 }} Overexpression of TERC is also observed in inflammatory conditions such as Type II diabetes and multiple sclerosis, due to TERC-mediated activation of the NF-κB inflammatory pathway.

TERC has been implicated as protective in osteoporosis, with its increased expression arresting the rate of osteogenesis.{{cite journal | vauthors = Gao GC, Yang DW, Liu W | title = LncRNA TERC alleviates the progression of osteoporosis by absorbing miRNA-217 to upregulate RUNX2 | journal = European Review for Medical and Pharmacological Sciences | volume = 24 | issue = 2 | pages = 526–534 | date = January 2020 | pmid = 32016954 | doi = 10.26355/eurrev_202001_20029 | s2cid = 211024218 }} Due to its overexpression in a range of cancer phenotypes, TERC has been investigated as a potential cancer biomarker. It was found to be an effective biomarker of lung squamous cell carcinoma (LUSC).{{cite journal | vauthors = Storti CB, de Oliveira RA, de Carvalho M, Hasimoto EN, Cataneo DC, Cataneo AJ, De Faveri J, Vasconcelos EJ, Dos Reis PP, Cano MI | title = Telomere-associated genes and telomeric lncRNAs are biomarker candidates in lung squamous cell carcinoma (LUSC) | journal = Experimental and Molecular Pathology | volume = 112 | pages = 104354 | date = February 2020 | pmid = 31837325 | doi = 10.1016/j.yexmp.2019.104354 | s2cid = 209385638 }}

{{clear}}

{{reflist}}

{{refbegin | 2}}

• {{cite journal | vauthors = de Lange T, Jacks T | title = For better or worse? Telomerase inhibition and cancer | journal = Cell | volume = 98 | issue = 3 | pages = 273–275 | date = August 1999 | pmid = 10458601 | doi = 10.1016/S0092-8674(00)81955-8 | s2cid = 14642341 | doi-access = free }}
• {{cite journal | vauthors = Marrone A, Dokal I | title = Dyskeratosis congenita: molecular insights into telomerase function, ageing and cancer | journal = Expert Reviews in Molecular Medicine | volume = 6 | issue = 26 | pages = 1–23 | date = December 2004 | pmid = 15613268 | doi = 10.1017/S1462399404008671 | s2cid = 38163343 }}
• {{cite journal | vauthors = Yamaguchi H | title = Mutations of telomerase complex genes linked to bone marrow failures | journal = Journal of Nippon Medical School = Nippon Ika Daigaku Zasshi | volume = 74 | issue = 3 | pages = 202–209 | date = June 2007 | pmid = 17625368 | doi = 10.1272/jnms.74.202 | doi-access = free }}
• {{cite journal | vauthors = Zaug AJ, Linger J, Cech TR | title = Method for determining RNA 3' ends and application to human telomerase RNA | journal = Nucleic Acids Research | volume = 24 | issue = 3 | pages = 532–533 | date = February 1996 | pmid = 8602368 | pmc = 145649 | doi = 10.1093/nar/24.3.532 }}
• {{cite journal | vauthors = Soder AI, Hoare SF, Muire S, Balmain A, Parkinson EK, Keith WN | title = Mapping of the gene for the mouse telomerase RNA component, Terc, to chromosome 3 by fluorescence in situ hybridization and mouse chromosome painting | journal = Genomics | volume = 41 | issue = 2 | pages = 293–294 | date = April 1997 | pmid = 9143511 | doi = 10.1006/geno.1997.4621 }}
• {{cite journal | vauthors = Zhao JQ, Hoare SF, McFarlane R, Muir S, Parkinson EK, Black DM, Keith WN | title = Cloning and characterization of human and mouse telomerase RNA gene promoter sequences | journal = Oncogene | volume = 16 | issue = 10 | pages = 1345–1350 | date = March 1998 | pmid = 9546436 | doi = 10.1038/sj.onc.1201892 | s2cid = 2699389 }}
• {{cite journal | vauthors = Mitchell JR, Wood E, Collins K | title = A telomerase component is defective in the human disease dyskeratosis congenita | journal = Nature | volume = 402 | issue = 6761 | pages = 551–555 | date = December 1999 | pmid = 10591218 | doi = 10.1038/990141 | bibcode = 1999Natur.402..551M | s2cid = 4430482 }}
• {{cite journal | vauthors = Chen JL, Blasco MA, Greider CW | title = Secondary structure of vertebrate telomerase RNA | journal = Cell | volume = 100 | issue = 5 | pages = 503–514 | date = March 2000 | pmid = 10721988 | doi = 10.1016/S0092-8674(00)80687-X | s2cid = 15642776 | doi-access = free }}
• {{cite journal | vauthors = Wong KK, Chang S, Weiler SR, Ganesan S, Chaudhuri J, Zhu C, Artandi SE, Rudolph KL, Gottlieb GJ, Chin L, Alt FW, DePinho RA | title = Telomere dysfunction impairs DNA repair and enhances sensitivity to ionizing radiation | journal = Nature Genetics | volume = 26 | issue = 1 | pages = 85–88 | date = September 2000 | pmid = 10973255 | doi = 10.1038/79232 | s2cid = 1873111 }}
• {{cite journal | vauthors = Mitchell JR, Collins K | title = Human telomerase activation requires two independent interactions between telomerase RNA and telomerase reverse transcriptase | journal = Molecular Cell | volume = 6 | issue = 2 | pages = 361–371 | date = August 2000 | pmid = 10983983 | doi = 10.1016/S1097-2765(00)00036-8 | doi-access = free }}
• {{cite journal | vauthors = Imoto I, Pimkhaokham A, Fukuda Y, Yang ZQ, Shimada Y, Nomura N, Hirai H, Imamura M, Inazawa J | title = SNO is a probable target for gene amplification at 3q26 in squamous-cell carcinomas of the esophagus | journal = Biochemical and Biophysical Research Communications | volume = 286 | issue = 3 | pages = 559–565 | date = August 2001 | pmid = 11511096 | doi = 10.1006/bbrc.2001.5428 }}
• {{cite journal | vauthors = Vulliamy T, Marrone A, Goldman F, Dearlove A, Bessler M, Mason PJ, Dokal I | title = The RNA component of telomerase is mutated in autosomal dominant dyskeratosis congenita | journal = Nature | volume = 413 | issue = 6854 | pages = 432–435 | date = September 2001 | pmid = 11574891 | doi = 10.1038/35096585 | bibcode = 2001Natur.413..432V | s2cid = 4348062 }}
• {{cite journal | vauthors = Pruzan R, Pongracz K, Gietzen K, Wallweber G, Gryaznov S | title = Allosteric inhibitors of telomerase: oligonucleotide N3'-->P5' phosphoramidates | journal = Nucleic Acids Research | volume = 30 | issue = 2 | pages = 559–568 | date = January 2002 | pmid = 11788719 | pmc = 99832 | doi = 10.1093/nar/30.2.559 }}
• {{cite journal | vauthors = Zhang RG, Zhang RP, Wang XW, Xie H | title = Effects of cisplatin on telomerase activity and telomere length in BEL-7404 human hepatoma cells | journal = Cell Research | volume = 12 | issue = 1 | pages = 55–62 | date = March 2002 | pmid = 11942411 | doi = 10.1038/sj.cr.7290110 | s2cid = 36839452 | doi-access = free }}
• {{cite journal | vauthors = Yang Y, Chen Y, Zhang C, Huang H, Weissman SM | title = Nucleolar localization of hTERT protein is associated with telomerase function | journal = Experimental Cell Research | volume = 277 | issue = 2 | pages = 201–209 | date = July 2002 | pmid = 12083802 | doi = 10.1006/excr.2002.5541 }}
• {{cite journal | vauthors = Chang JT, Chen YL, Yang HT, Chen CY, Cheng AJ | title = Differential regulation of telomerase activity by six telomerase subunits | journal = European Journal of Biochemistry | volume = 269 | issue = 14 | pages = 3442–3450 | date = July 2002 | pmid = 12135483 | doi = 10.1046/j.1432-1033.2002.03025.x | doi-access = free }}
• {{cite journal | vauthors = Gavory G, Farrow M, Balasubramanian S | title = Minimum length requirement of the alignment domain of human telomerase RNA to sustain catalytic activity in vitro | journal = Nucleic Acids Research | volume = 30 | issue = 20 | pages = 4470–4480 | date = October 2002 | pmid = 12384594 | pmc = 137139 | doi = 10.1093/nar/gkf575 }}
• {{cite journal | vauthors = Sood AK, Coffin J, Jabbari S, Buller RE, Hendrix MJ, Klingelhutz A | title = p53 null mutations are associated with a telomerase negative phenotype in ovarian carcinoma | journal = Cancer Biology & Therapy | volume = 1 | issue = 5 | pages = 511–517 | year = 2003 | pmid = 12496479 | doi = 10.4161/cbt.1.5.167 | s2cid = 45381814 | doi-access = free }}
• {{cite journal | vauthors = Antal M, Boros E, Solymosy F, Kiss T | title = Analysis of the structure of human telomerase RNA in vivo | journal = Nucleic Acids Research | volume = 30 | issue = 4 | pages = 912–920 | date = February 2002 | pmid = 11842102 | pmc = 100349 | doi = 10.1093/nar/30.4.912 }}

{{refend}}

• [https://www.ncbi.nlm.nih.gov/bookshelf/br.fcgi?book=gene&part=dkc GeneReviews/NCBI/NIH/UW entry on Dyskeratosis Congenita]
• [https://www.ncbi.nlm.nih.gov/bookshelf/br.fcgi?book=gene&part=pf GeneReviews/NCBI/NIH/UW entry on Pulmonary Fibrosis, Familial]
• [https://www.ncbi.nlm.nih.gov/sites/entrez?Db=gene&Cmd=ShowDetailView&TermToSearch=7012 EntrezGene page for TERC]
• {{Rfam|id=RF00024|name=Vertebrate telomerase RNA}}
• {{Rfam|id=RF00025|name=Ciliate telomerase RNA}}
• {{Rfam|id=RF01050|name=Saccharomyces telomerase}}

{{DNA replication}}

Category:Non-coding RNA

Category:Telomere-related genes